Genital Wart and Sexuality in Adolescence

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-01

Study Completion Date

2021-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The adolescence is a landmark in perceiving the sexuality and awareness about the sexual experiences. Genitals warts were shown to be a potential risk to impair the sexual functions in women. Adolescence is a vulnerable period in which the individuals may be prone to the negative effects of the disorders affecting sexual functions such as genital warts. The current study aimed to investigate the impact of genital warts on sexual functions in female adolescents.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile

NCT01483794

Condylomata Acuminata

UNKNOWN

Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients

NCT03153566

Genital Wart

UNKNOWN PHASE3

Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts

NCT05761002

Human Papilloma Virus Anogenital Wart

UNKNOWN NA

Typing of Human Papilloma Virus (HPV) From Female Genital Warts

NCT01192282

Genital Warts Human Papilloma Virus

COMPLETED

The Psychosocial and Economic Burden of Genital Warts

NCT01520194

Female Genital Warts

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This current study aimed to elucidate the impact of genital warts on female sexual function in adolescence. The current study also targeted to reveal whether there is any correlation between the genital warts and the female sexual dysfunction, as well as the sexuality related distress. The current study is conducted at Youth Center Outpatient Clinic of Ankara City Hospital which is a high-volume tertiary health care center in Turkey. The study was prospectively designed and data were collected between the 1 August 2020 and 1 February 2021. Totally 90 female adolescents between the age of 17-21 who had regular sexual intercourse with heterosexual partners were included. The Study group composed of 45 adolescents who had genital warts and the Control group included 45 healthy adolescents. Female sexual function Index (FSFI), Arizona Sexual Experiences Scale (ASEX) and Female Sexual Dysfunction Scale (FSDS) scores were compared between the two groups to evaluate the sexual functions. Difference between two independent means (two groups) power analysis demonstrated that this study achieved a power of 0.99, 0.98 , 0.99 with a 5% level of significance for comparison of 45 adolescents with genital warts and 45 healthy adolescents in terms of FSFI, ASEX, and FSDS scores, respectively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adolescent Development Genital Wart Sexual Dysfunction Sexual Disorder, Physiological

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescents with genital warts (Study Group)

The Study group included adolescents who was diagnosed as positive for genital warts during the examination.

Clinical assessment

Intervention Type OTHER

FSFI, ASEX and FSDS scores were compared between the adolescents with (Study group) or without (Control group) genital warts.

Healthy adolescents (Control Group)

The Control group was composed of healthy adolescents who admitted for only contraceptive counselling.

Clinical assessment

Intervention Type OTHER

FSFI, ASEX and FSDS scores were compared between the adolescents with (Study group) or without (Control group) genital warts.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical assessment

FSFI, ASEX and FSDS scores were compared between the adolescents with (Study group) or without (Control group) genital warts.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The Study group included adolescents who was diagnosed as positive for genital warts during the examination.
* The Control group was composed of healthy adolescents who admitted for contraceptive counselling.

Exclusion Criteria

* Chronical disease including rheumatological diseases, renal failure, diabetes mellitus, hypertension, dyslipidemia, obesity, thyroid dysfunction, cardiopulmonary diseases, malignancy, cerebrovascular diseases, psychiatric and mental disorders, cerebrovascular diseases, inflammatory bowel diseases.
* Drug administration which may interfere sexual function.
* Surgical intervention to genital organs.
* History of pregnancy, delivery, and/or breastfeeding.

Minimum Eligible Age

17 Years

Maximum Eligible Age

21 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes